Latest News of AORT
Endospan hits enrolment milestone in aortic arch stent trial
Endospan has completed enrollment in a clinical trial for its NEXUS stent graft treating aortic arch disease. The trial aims to support FDA approval and enhance patient outcomes. The company raised $2...
Echo IQ Shares Surge 25% After FDA Clears AI Solution for Aortic Stenosis
Australian biotech firm Echo IQ saw a 25% surge in stock price after receiving FDA clearance for its AI-driven cardiovascular diagnostic tool. The company is set to capitalize on commercial opportunit...
Artivion's (NYSE:AORT) Returns Have Hit A Wall
To find potential multi-bagger investments, look for companies with increasing Return on Capital Employed (ROCE) and growing capital employed. Artivion's ROCE of 3.0% underperforms the industry averag...
-
Do You Think Artivion (AORT) Stock Could Soar?
By Yahoo! Finance | 5 months agoWasatch Global Investors released its investor letter for the first quarter of 2024, showcasing strong performance in micro-cap equities. The top holdings include Artivion, Inc. (NYSE:AORT), a medical...